PsychNotes: Clinical Pkt Guide
ASO Keyword Dashboard
Tracking 166 keywords for PsychNotes: Clinical Pkt Guide in Google Play
PsychNotes: Clinical Pkt Guide tracks 166 keywords (2 keywords rank; 164 need traction). Key metrics: 0% top-10 coverage, opportunity 70.6, difficulty 44.8, best rank 11.
Essential information on psychotropic drugs
Tracked keywords
166
2 ranked • 164 not ranking yet
Top 10 coverage
0%
Best rank 11 • Latest leader 17
Avg opportunity
70.6
Top keyword: clinical
Avg difficulty
44.8
Lower scores indicate easier wins
Opportunity leaders
- 62.1
clinical
Opportunity: 74.0 • Difficulty: 37.6 • Rank 17
Competitors: 77
- 64.0
managed
Opportunity: 74.0 • Difficulty: 41.3 • Rank —
Competitors: 310
- 64.8
patient
Opportunity: 74.0 • Difficulty: 39.5 • Rank —
Competitors: 195
- 64.5
trial
Opportunity: 74.0 • Difficulty: 45.3 • Rank —
Competitors: 765
- 60.2
sample
Opportunity: 74.0 • Difficulty: 40.3 • Rank —
Competitors: 251
Unranked opportunities
managed
Opportunity: 74.0 • Difficulty: 41.3 • Competitors: 310
patient
Opportunity: 74.0 • Difficulty: 39.5 • Competitors: 195
trial
Opportunity: 74.0 • Difficulty: 45.3 • Competitors: 765
sample
Opportunity: 74.0 • Difficulty: 40.3 • Competitors: 251
assessment
Opportunity: 74.0 • Difficulty: 37.4 • Competitors: 118
High competition keywords
time
Total apps: 384,338 • Major competitors: 16,191
Latest rank: — • Difficulty: 58.5
new
Total apps: 368,929 • Major competitors: 21,444
Latest rank: — • Difficulty: 59.8
access
Total apps: 339,043 • Major competitors: 11,559
Latest rank: — • Difficulty: 59.5
download
Total apps: 335,308 • Major competitors: 15,858
Latest rank: — • Difficulty: 56.8
easy
Total apps: 327,701 • Major competitors: 14,519
Latest rank: — • Difficulty: 57.3
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| clinical | 74 | 100 | 38 | 62 7,886 competing apps Median installs: 750 Avg rating: 1.8 | 17 | 11 | 77 major competitor apps |
| treatments | 73 | 100 | 35 | 56 3,455 competing apps Median installs: 458 Avg rating: 1.9 | 20 | 20 | 99 major competitor apps |
| free | 65 | 100 | 60 | 88 322,124 competing apps Median installs: 4,278 Avg rating: 2.3 | — | — | 22,301 major competitor apps |
| download | 65 | 100 | 57 | 88 335,308 competing apps Median installs: 1,667 Avg rating: 2.0 | — | — | 15,858 major competitor apps |
| play | 66 | 100 | 62 | 85 206,958 competing apps Median installs: 6,219 Avg rating: 2.3 | — | — | 18,529 major competitor apps |
| new | 65 | 100 | 60 | 89 368,929 competing apps Median installs: 2,547 Avg rating: 2.1 | — | — | 21,444 major competitor apps |
| health | 69 | 100 | 50 | 77 69,675 competing apps Median installs: 648 Avg rating: 1.9 | — | — | 1,824 major competitor apps |
| 69 | 100 | 50 | 77 69,407 competing apps Median installs: 2,060 Avg rating: 2.1 | — | — | 2,876 major competitor apps | |
| follow | 69 | 100 | 53 | 78 82,713 competing apps Median installs: 1,487 Avg rating: 2.0 | — | — | 4,128 major competitor apps |
| subscription | 72 | 100 | 53 | 70 24,861 competing apps Median installs: 4,466 Avg rating: 2.3 | — | — | 1,674 major competitor apps |
| change | 68 | 100 | 53 | 79 90,509 competing apps Median installs: 3,508 Avg rating: 2.2 | — | — | 5,877 major competitor apps |
| try | 69 | 100 | 58 | 78 79,784 competing apps Median installs: 5,732 Avg rating: 2.3 | — | — | 7,164 major competitor apps |
| easy | 65 | 100 | 57 | 88 327,701 competing apps Median installs: 1,985 Avg rating: 2.0 | — | — | 14,519 major competitor apps |
| care | 70 | 100 | 50 | 76 56,144 competing apps Median installs: 1,254 Avg rating: 2.0 | — | — | 2,569 major competitor apps |
| medication | 73 | 100 | 36 | 59 5,089 competing apps Median installs: 714 Avg rating: 1.8 | — | — | 105 major competitor apps |
| product | 70 | 100 | 49 | 75 52,620 competing apps Median installs: 1,062 Avg rating: 1.8 | — | — | 2,087 major competitor apps |
| information | 65 | 100 | 55 | 86 267,617 competing apps Median installs: 1,023 Avg rating: 1.9 | — | — | 7,567 major competitor apps |
| content | 67 | 100 | 58 | 81 130,776 competing apps Median installs: 1,982 Avg rating: 2.0 | — | — | 5,602 major competitor apps |
| choose | 66 | 100 | 56 | 84 195,566 competing apps Median installs: 2,302 Avg rating: 2.1 | — | — | 12,116 major competitor apps |
| call | 70 | 100 | 56 | 74 47,550 competing apps Median installs: 2,865 Avg rating: 2.1 | — | — | 2,699 major competitor apps |
| menu | 71 | 100 | 54 | 73 40,588 competing apps Median installs: 612 Avg rating: 1.9 | — | — | 1,228 major competitor apps |
| time | 64 | 100 | 58 | 89 384,338 competing apps Median installs: 1,263 Avg rating: 2.0 | — | — | 16,191 major competitor apps |
| available | 66 | 100 | 60 | 84 199,899 competing apps Median installs: 2,015 Avg rating: 2.1 | — | — | 9,729 major competitor apps |
| mobile | 65 | 100 | 56 | 87 280,792 competing apps Median installs: 1,234 Avg rating: 2.0 | — | — | 10,253 major competitor apps |
| provide | 67 | 100 | 52 | 82 136,849 competing apps Median installs: 1,367 Avg rating: 1.9 | — | — | 4,403 major competitor apps |
App Description
Essential information on psychotropic drugs
A Davis’s Notes Title, Perfect wherever you are…in class, in clinical, and in any practice setting! This handy guide delivers quick access to need-to-know information on DSM-5 disorders and treatments, psychotropic drugs, documentation, and patient education. No other resource delivers as much information in a format that’s as easy to read, easy to access the content on your mobile device.
KEY FEATURES
* Coverage of documentation • psychiatric medications, restraints, and seclusion • DSM-5 disorders and treatments • and patient education and care
* Basic behavioral theories at a glance
* Key aspects of psychiatric and crisis interventions
* General mental status assessments and exams, with focused assessments for adult and geriatric populations, including mini-cognitive assessment instrument for dementia and rating scale for Lewy Body diseases
* Essential information on psychotropic drugs
* Client/family education tables, tips, and strategies
* Cultural considerations and assessment tool
NEW TO THIS EDITION
* Addresses important topics such as Telepsychiatry and Teletherapy and more importantly the pandemic and its effect on mental health, both on individuals as well as health care providers.
* Several new psychotropics — for tardive dyskinesia, PTSD, treatment-resistant depression, and also a new medication for schizophrenia.
* Crises that deal with Covid and PTSD as well as the military, and geriatrics in a clinical pocket companion.
* Multiaxial assessment, CAGE, self-administered patient health questionnaires 2 and 9, and many other assessment tools
* Clinical pearls throughout to provide practical on-the-spot advice
* UPDATED & REVISED! All content thoroughly reviewed, revised, and updated to incorporate the newest knowledge in the field, including new drugs and drug updates.
ISBN 13: 9781719645454
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $29.99
Payment will be charged to your Google Play Account at confirmation of purchase. Initial purchase includes a 1-year subscription with regular content updates. Your subscription will automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. If you do not choose to renew, you can continue to use the product but will not receive content updates. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to Google Play Store. Tap Menu Subscriptions, then select the subscription you want to modify. Follow the instructions on the screen to pause, cancel or change your subscription. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Author(s): Maxine Papadakis, Stephen McPhee, Michael Rabow, Kenneth McQuaid
Publisher: The McGraw-Hill Companies, Inc."